F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment

While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.

View original article
Contributor: Carl Zimmer and Christina Jewett